| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |